SURI Stock Overview
Engages in the manufacture and sale of gloves in Indonesia. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
PT Maja Agung Latexindo Tbk Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | Rp82.00 |
| 52 Week High | Rp750.00 |
| 52 Week Low | Rp81.00 |
| Beta | 0 |
| 11 Month Change | -18.00% |
| 3 Month Change | -20.39% |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -49.38% |
Recent News & Updates
Recent updates
Shareholder Returns
| SURI | ID Medical Equipment | ID Market | |
|---|---|---|---|
| 7D | -9.9% | -1.0% | -2.2% |
| 1Y | n/a | 1.0% | 9.3% |
Return vs Industry: Insufficient data to determine how SURI performed against the ID Medical Equipment industry.
Return vs Market: Insufficient data to determine how SURI performed against the ID Market.
Price Volatility
| SURI volatility | |
|---|---|
| SURI Average Weekly Movement | 8.8% |
| Medical Equipment Industry Average Movement | 6.8% |
| Market Average Movement | 5.5% |
| 10% most volatile stocks in ID Market | 12.6% |
| 10% least volatile stocks in ID Market | 2.4% |
Stable Share Price: SURI has not had significant price volatility in the past 3 months compared to the ID market.
Volatility Over Time: SURI's weekly volatility has decreased from 18% to 9% over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | 300 | Imelda Lin | malgloves.com |
PT Maja Agung Latexindo Tbk engages in the manufacture and sale of gloves in Indonesia. It offers examination, industrial, and specialty gloves; and concentrated latex. The company serves medical and healthcare, industrial, and beauty care industries.
PT Maja Agung Latexindo Tbk Fundamentals Summary
| SURI fundamental statistics | |
|---|---|
| Market cap | Rp557.43b |
| Earnings (TTM) | Rp5.10b |
| Revenue (TTM) | Rp108.04b |
101.8x
P/E Ratio4.8x
P/S RatioIs SURI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SURI income statement (TTM) | |
|---|---|
| Revenue | Rp108.04b |
| Cost of Revenue | Rp97.16b |
| Gross Profit | Rp10.88b |
| Other Expenses | Rp5.78b |
| Earnings | Rp5.10b |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.81 |
| Gross Margin | 10.07% |
| Net Profit Margin | 4.72% |
| Debt/Equity Ratio | 1.0% |
How did SURI perform over the long term?
See historical performance and comparison